Journal Information

Statistics

Follow this link to access the full text of the article

Brief Comunication
52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience
Eficacia a medio plazo (52 semanas) de tildrakizumab en el tratamiento de la psoriasis moderada a severa: un estudio multicéntrico de práctica clínica
F.J. Melgosa Ramosa,
Corresponding author
javimelgo@gmail.com

Corresponding author.
, A. Mateu Puchadesa, J. Matáix-Díazb, L. Schneller-Pavelescuc, I. Belinchón-Romerod, S. Santos Alarcóne
a Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia, Spain
b Department of Dermatology, Hospital Marina Alta, Vila-Joyosa, Alicante, Spain
c Department of Dermatology, Hospital de la Vega Baja, Orihuela, Alicante, Spain
d Department of Dermatology, General University Hospital of Alicante, Alicante, Spain
e Department of Dermatology, University Hospital Virgen de los Lirios, Alcoy, Alicante, Spain
Read
1981
Times
was read the article
589
Total PDF
1392
Total HTML
Share statistics
Article information
ISSN: 00017310
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 115 74 189
2024 October 145 69 214
2024 September 137 54 191
2024 August 222 105 327
2024 July 207 60 267
2024 June 174 64 238
2024 May 182 56 238
2024 April 210 107 317

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?